Article Details
Retrieved on: 2025-08-15 10:58:21
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
In urothelial carcinoma, HER2-targeted therapies, such as tyrosine kinase inhibitors, monoclonal antibodies and antibody–drug conjugate (ADCs) have ...
Article found on: www.nature.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here